Gastrin and Gastrin Sequences

What is gastrin?

One of the classical digestive hormones is gastrin. In 1964, the antral mucosa of pigs was initially used to purify gastrin. The four amino acid residues at the C-terminus that activate the receptor are conserved in vertebrates. While gastrins from mammals have a sulfated tyrosine at the sixth residue from the C-terminus, gastrins from nonmammalian species have it at the seventh residue from the C-terminus. The G-cells of the stomach mucosa are the primary sites of gastrin expression. Nutrients and gastrin-releasing peptide trigger gastrin release, while somatostatin inhibits it due to the high concentration of H+ ions in the gastric mucosa. Gastrin triggers the release of histamine from the enterochromaffin-like cells through the CCK2R receptor, and the parietal cells' histamine H2 receptor then triggers the release of stomach acid. In addition, parietal cells' CCK2R is activated by gastrin, which causes the secretion of gastric acids. According to reports, Zollinger-Ellison syndrome occurs when a tumor that secretes gastrin ends up in the pancreas or duodenum.

Gastrin function

An important role of the peptide hormone gastrin is to promote the expansion of the stomach's mucosal lining, the movement of the stomach muscles, and the release of hydrochloric acid (HCl) into the stomach. It can be found in the duodenal and gastric antrum G cells. After peptides, amino acids, gastric distention, or an increased stomach pH have been ingested, the main triggers for the release of gastrin are vagal and gastrin-releasing peptide (GRP) stimulation. On the flip side, paracrine suppression by somatostatin and a lower stomach pH reduce gastrin secretion.

The gastric fundus and heart receive the majority of the parietal cells that release HCl, and the secreted gastrin is transported there by the blood. In order to activate pepsinogen, which aids in stomach protein digestion and releases cobalamin (vitamin B12) from its salivary R-protein carrier, hydrochloric acid is required. The diagnosis of gastrinoma, a tumor that produces gastrin, is the primary clinical reason for gastrin assaying. There is mounting evidence that gastrin may play a role in the development of several malignancies, including gastric cancer.

Gastrin has been demonstrated to increase cell migration, invasion, apoptosis, and tubulogenesis in addition to its well-documented proliferative properties. As new gastrin targets are discovered and their regulation studied, the reasoning for these effects is becoming clearer. It has recently been acknowledged that gastrin controls the expression of several molecules that play a significant role in the remodeling of the extracellular matrix. These molecules include plasminogen activator inhibitors (PAIs), matrix metalloproteinases (MMPs), and tissue inhibitors of metalloproteinases. The fact that gastrin can increase the expression of molecules like matrix metalloproteinases (MMPs) and transient integrin-binding protein (TIMPs), which seem to have opposite effects on matrix remodelling, suggests that the underlying mechanisms are likely to be intricate, requiring precise spatial and temporal organization and depending on paracrine cascades, in part. There have been reports of gastrin's seemingly contradictory effects on cell survival, such as its ability to upregulate clusterin, a pro-survival factor, and PAI-2, a pro-apoptotic factor.

Paracrine release of histamine from ECL cells operates on acid-secreting parietal cells, which in turn affects gastrin's principal physiological function; there's also evidence to imply that some of gastrin's unique activities may be indirect. In the case of PAI-2, for instance, gastrin can activate it directly via the CCK2 receptor in ECL cells and in mucous cells that do not, or it can be activated indirectly by paracrine substances like IL-8 and prostaglandin E2. And there are clear differences in the transcriptional activators used by the paracrine and direct pathways to increase PAI-2 expression. Paracrine processes were established for TFF1, and it has been proven that gastrin regulates the expression of the protective gastric Trefoil factors (TFFs) in both mouse and human gastric cancer cell lines. Even though parietal cells do not often secrete acid in response to gastrin, they do have functioning CCK2 receptors. The release of paracrine signaling molecules and an upregulation of genes including ezrin, HBEFG, and PAI-1 may result from the activation of parietal cell CCK2 receptors by gastrin.

Gastrin peptide structure

The primary function of the classical gut peptide hormone known as gastrin is to stimulate the production of stomach acid. G cells in the stomach antrum and the upper small intestine both contribute to its production, albeit to far lesser degrees than the colon and pancreas. The final result of gastrin processing is known as gastrin, and it consists of 17 or 34 amino acids amidated. Comparable to gastrin in its C-terminal tetrapeptide amide is the related hormone CCK, which triggers the production of pancreatic enzymes. The gastrin gene, like many others encoding peptide hormones, first encodes a big precursor molecule called preprogastrin, which has 101 amino acids. The N-terminal signal peptide is cleaved to produce a smaller molecule called progastrin, which has 80 amino acids. Within secretory vesicles, endopeptidases and carboxy-peptidases further process progastrin to produce gastrins that are extended with glycine. Proteolytic cleavage leads to the formation of mature amidated gastrin17 after peptidyl α-amidating monooxygenase amidates the C terminus of glycine-extended gastrin34. Progastrin and the gastrins extended by glycine make up less than 10% of the gastrins in the blood of healthy people. In the antrum, you can find gastrin amide and the C-terminal flanking peptide of progastrin in amounts that are almost equal.

The two main forms of amidated gastrin that are kept are gastrin 17 (tyrosine-sulfated and nonsulfated), and their amounts are almost similar. Although 50% of duodenal gastrin is gastrin34, less than 10% of antral gastrin amide is gastrin34. Although both gastrin17 and gastrin34 promote acid secretion to comparable degrees, the latter's action is more long-lasting due to its approximately fivefold slower clearance rate. Due to its delayed clearance and preferential release from the duodenum, circulating gastrin34 is most abundant between meals. The primary component of meal-stimulated gastrin is gastrin17.

As a hormone, gastrin primarily controls stomach acid secretion via the CCK-2 receptor. At the heart of the regulation of gastrin secretion is the gastrin-acid feedback loop, in which an increase in gastrin acidity restricts secretion and a reduction in acidity enhances secretion. There are two ways in which gastrin stimulates parietal cell activity. Although gastrin stimulates HDC production and histamine release from fundic ECL cells, the most critical pathway likely includes direct effects on parietal cells via gastrin receptors. The parietal cell is subsequently activated by histamine. Somatostatin, which blocks the production of gastrin and stomach acid, is another crucial ingredient.

Gastrin-releasing peptide

Different human tissues contain Gastrin-releasing peptide (GRP), which is the 27-amino-acid mammalian equivalent of the 14-amino-acid amphibian peptide bombesin (reviewed in Ref. 1), with the exception of the brain, GI tract, and lungs. GRP has a dual role as a hormone that stimulates neuroculation and a growth factor that targets certain tissues. It is believed that GRP regulates pituitary hormone production and secretion; it is most abundant in the hypothalamus and brain stem in the central nervous system. The intrapancreatic ganglia, submucosal and myenteric plexuses of the stomach and intestine, and other intrinsic neurons in the gut are also localized to GRP. In the gastrointestinal tract, GRP controls motility of the gut and secretion of enteropancreatic hormone, and it may also function as an epithelial growth factor. However, GRP is found in pulmonary neuroendocrine cells (PNECs) in the lungs, particularly in the developing lungs of fetuses (2). accelerated DNA synthesis by mesenchymal, bronchial, and alveolar epithelial cells and accelerated maturation with elevated levels of surfactant phospholipids were seen in a mouse model of fetal alcohol syndrome (GERS), where bombesin, which has physiological effects equivalent to GRP, was given in utero. Fetal lung organ cultures from mice and humans also showed signs of enhanced development and maturation.

Among the bombesin-like peptides, which also comprise neuromedin B (NMB), is the mammalian bombesin homolog known as gastrin-releasing peptide (GRP). Among GRP's many cellular physiological functions are the control of hunger, digestion, and glucose homeostasis; it exerts these effects via bombesin receptors (BB1-3, with BB2 having the highest affinity). Among the many digestive peptides secreted by mammals in response to GRP are insulin, pancreatic glucagon, pancreatic polypeptide, enteroglucan, motilin, vasoactive intestinal peptide, and a rise in plasma gastrin and stomach acid secretion. Since the hypothalamus contains GRP and BB receptors at critical feeding locations, a lack of food reduces brain Mice deficient in BB2 or BB3 receptors and those with GRP mRNA expression exhibit metabolic dysregulations, hyperphagia, insulin resistance, and obesity. It has been shown that a synthetic BB3 agonist can cause weight reduction and an increase in metabolic rate in mice and dogs, indicating that the GRP receptor could be a therapeutic target for obesity.

Gastrin 1

Human gastrin-1 is mostly produced in the intestines and functions to promote gastric acid secretion and lectin-like protein Reg production by means of PKC and RhoA activation. As a gastritis marker, it is utilized.

Gastrin 17

Gastrin-17 is the primary gastrin found in tissue extracts from the stomach and duodenum. Gastrin-17 (G-17) was suggested as a measure of antral mucosa function in research conducted in Finland. The only cells in the body that can make G-17, a subgroup of gastrin with 17 amino acids, are the antral G cells. There is a direct correlation between intraluminal pH and G-17 levels. Specifically, they are typically low in acidic environments and unusually high in achloridria or hypochloridria. After eating, both levels of postprandial G-17 and the severity of antral atrophy decreased, according to Sipponen et al., who studied 100 dyspeptic patients. The authors found that comparing the accuracy of diagnosing antral atrophy by testing post-prandial G-17 levels (after a standard protein-rich drink) to fasting G-17 levels was marginally superior.

Gastrin 34

Posttranslational changes of progastrin, including sulfation, provide the mature 34-amino acid gastrin-34 (G34). G34 can be further split into the shorter 17-amino acid G17. The generation and secretion of gastrin are primarily regulated by gastric pH, with elevated pH levels resulting in increased gastrin concentrations. The principal circulating variants of gastrin are amidated G17 and large gastrin, gastrin 1–34 (G-34). In the interdigestive (basal) state, the predominant form of gastrin identified in human serum is G-34. In humans, the duodenal mucosa generates substantial quantities of G-34, unlike other species.

FAQ

Is gastrin a hormone?

Yes. Gastrin is the primary hormonal modulator of the gastrointestinal phase of acid secretion, according to investigations of immunoneutralization in animals and gastrin infusions in people. Gastrin also has a role in the cephalic and intestinal stages, but the magnitude of its contribution varies by species. For example, gastrin is more vital in dogs than it is in rats.

References

1. Dockray G., et al., Gastrin: old hormone, new functions, Pflügers Archiv, 2005, 449: 344-355.
2. Ferrand A., et al., Gastrin and cancer: a review, Cancer letters, 2006, 238(1): 15-29.
3. Dimaline R., et al., Novel roles of gastrin, The Journal of physiology, 2014, 592(14): 2951-2958.
4. Czepielewski R S., et al., Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils, Proceedings of the National Academy of Sciences, 2012, 109(2): 547-552.
5. Sunday M E. Cell-specific localization of neuropeptide gene expression: gastrin-releasing peptide or mammalian bombesin[M]//Methods in Neurosciences. Academic Press, 1991, 5: 123-136.
6. Volkoff H. Fish as models for understanding the vertebrate endocrine regulation of feeding and weight, Molecular and cellular endocrinology, 2019, 497: 110437.
7. di Mario F., et al., Non-invasive tests in gastric diseases, Digestive and liver disease, 2008, 40(7): 523-530.
8. Yu S., et al., Analytical and clinical performance of a liquid chromatography–tandem mass spectrometry method for measuring gastrin subtypes G34 and G17 in serum, Clinical Chemistry, 2021, 67(9): 1220-1229.